Advocate Spotlight April 2022 – Brad Power
Brad Power was a process innovation researcher and consultant with more than 35 years of experience, as well as an author of more than 75 articles for the Harvard Business Review, when he was diagnosed with lymphoma in 2018. After successfully completing a standard course of chemotherapy, he has no evidence of disease.
While attending a Harvard Medical School conference on personalized medicine, Brad discussed his experience as a patient. Many attendees eagerly told Brad that he had a voice. It was then that he realized that advocacy was his calling.
Brad resolved to focus his skills and experience on accelerating innovation in cancer treatment.
Read the rest of this article on the National Coalition for Cancer Survivorship site.